The Resveratrol Twist: Cis vs. Trans

The Resveratrol Twist: Cis vs. Trans

Resveratrol (trans-3,5,4′-trihydroxystilbene) is a polyphenolic phytoalexin produced by several plants in response to biotic and abiotic stress and acts as a defence against microbes. Although resveratrol is naturally present in grapes, peanuts, almonds, blueberries and dark chocolate, the highest concentration of resveratrol is found in wine (4–20 mg/L)1. Although there are various reported health benefits of resveratrol, its stereoisomeric forms are often overlooked. This article will explore the stereoisomeric forms of resveratrol – cis and trans.

What are stereoisomers?

Stereoisomers are molecules that have same chemical formula but different arrangements of functional group atoms in space. Stereoisomers exist in cis-trans configurations. In cis-resveratrol (c-RESV), the stilbene functional group is on the same side of the plane, while in trans-resveratrol (t-RESV), this functional group lies on the opposite side.

Adapted from https://pubchem.ncbi.nlm.nih.gov/

Which form is more effective biologically?

A comparative study on the antioxidant activity of diastereomers of resveratrol showed that t-RESV is more efficient in protecting keratinocytes from cumene hydroperoxide mediated oxidative damage than c-RESV 2. However, more research is needed to compare the other benefits of the two forms of resveratrol.

Trans-resveratrol: Beyond the boundary of antioxidant molecule

Besides having excellent antioxidant properties, researchers suggest it possesses excellent anti-inflammatory, anti-diabetic, neuroprotective and cardioprotective activities 3–5.

In a 14-week double-blind, placebo-controlled trial, the effect of resveratrol on postmenopausal women’s mood and Cognitive health was assessed. Resveratrol supplementation (75 mg of 99% t-RESV twice daily) was observed to improve mood and cognitive health in postmenopausal women5.

Another 24-week clinical trial investigated the hypoglycaemic effects of resveratrol in a cohort of 110 participants. Resveratrol supplementation (200 mg, once daily) significantly reduced plasma glucose and inflammatory markers (CRP, TNF-α, IL-6)4.

In conclusion, trans-resveratrol is more prominent than cis-resveratrol found naturally in plants and has more pronounced biological activity.

References

(1)      Tian, B.; Liu, J. Resveratrol: A Review of Plant Sources, Synthesis, Stability, Modification and Food Application. Journal of the Science of Food and Agriculture. John Wiley and Sons Ltd March 15, 2020, pp 1392–1404. https://doi.org/10.1002/jsfa.10152.

(2)      Bononi, I.; Tedeschi, P.; Mantovani, V.; Maietti, A.; Mazzoni, E.; Pancaldi, C.; Brandolini, V.; Tognon, M. Antioxidant Activity of Resveratrol Diastereomeric Forms Assayed in Fluorescent-Engineered Human Keratinocytes. Antioxidants 2022, 11 (2). https://doi.org/10.3390/antiox11020196.

(3)      Kazemirad, H.; Kazerani, H. R. Cardioprotective Effects of Resveratrol Following Myocardial Ischemia and Reperfusion. Mol Biol Rep 2020, 47 (8), 5843–5850. https://doi.org/10.1007/s11033-020-05653-7.

(4)      Mahjabeen, W.; Khan, D. A.; Mirza, S. A. Role of Resveratrol Supplementation in Regulation of Glucose Hemostasis, Inflammation and Oxidative Stress in Patients with Diabetes Mellitus Type 2: A Randomized, Placebo-Controlled Trial. Complement Ther Med 2022, 66. https://doi.org/10.1016/j.ctim.2022.102819.

(5)      Evans, H. M.; Howe, P. R. C.; Wong, R. H. X. Clinical Evaluation of Effects of Chronic Resveratrol Supplementation on Cerebrovascular Function, Cognition, Mood, Physical Function and General Well-Being in Postmenopausal Women—Rationale and Study Design. Nutrients 2016, 8 (3). https://doi.org/10.3390/nu8030150.

Back to blog
Author Image

About the Author

Dr. Sunny Gupta, Ph.D. Cancer Biology

LinkedIn

Dr. Sunny is an accomplished researcher with expertise in natural products and their therapeutic applications. He has extensive experience in designing and executing assays for the preclinical testing of natural products, both in vitro and in vivo, with a focus on diseases such as cancer and dengue. Sunny’s research integrates traditional natural compounds (Ayurveda) with modern scientific approaches to develop and validate affordable and sustainable treatments. He holds an M.Tech in Biotechnology from Maulana Abul Kalam Azad University of Technology, Kolkata, and a Ph.D. in Cancer Biology from the Indian Institute of Technology Delhi, India.